Publications by authors named "Nick Duncan"

Claim this Profile
A
An evaluation of a real-world, multi-disciplinary, treatment-free remission programme for patients with Chronic Myeloid Leukaemia.
Eleanor Jones, Joanne Ewing, Hayder Hussein, Bernard Maybury, Manoj Raghavan, Nick Duncan

J Oncol Pharm Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT).
Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, Maria-Estela Moreno-Martinez, Khalil Ben Hassine, Nick Duncan

Bone Marrow Transplant· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function.
Pinkie Chambers, Matthew Watson, John Bridgewater, Martin D Forster, Rebecca Roylance, Nick Duncan

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML).
Saffiya Khadam, Teresa Chu, Nigel Deekes, David FitzGerald, Andrea Preston, Nick Duncan

J Oncol Pharm Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey.
Nick Duncan, Maria-Estela Moreno-Martinez, Vera Pires, Vera Domingos, Agnes Bonnin

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners.
Grace Chazan, Jennifer Jupp, Tiene Bauters, Nick Duncan, Kellie Jones Weddle

J Oncol Pharm Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Maria A V Marzolini, Varun Mehra, Kirsty J Thomson, Eleni Tholouli, Adrian J C Bloor, Nick Duncan

Blood Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.
Charles Craddock, Sandeep Nagra, Andrew Peniket, Cassandra Brookes, Laura Buckley, Nick Duncan

Haematologica· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
Charles Craddock, James Anson, Patrick Chu, Andrew Dodgson, Nick Duncan

Expert Opin Drug Saf· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis